Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
2015年7月11日 - 6:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 000-28414
Urologix, Inc. |
(Exact name of registrant as specified in its charter) |
|
14405 21st Avenue North |
Minneapolis, MN 55447 |
(612) 475-1400 |
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) |
|
Common Stock |
Series A Junior Participating Preferred Stock Purchase Rights |
(Title of each class of securities covered by this Form) |
|
None |
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) |
Please place an X in the box(es)
to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
Rule 12g-4(a)(1) |
☒ |
|
|
Rule 12g-4(a)(2) |
☐ |
|
|
Rule 12h-3(b)(1)(i) |
☒ |
|
|
Rule 12h-3(b)(1)(ii) |
☐ |
|
|
Rule 15d-6 |
☒ |
Approximate number of holders of
record as of the certification or notice date: 214
Pursuant to the requirements of
the Securities Exchange Act of 1934, Urologix, Inc. has caused this certification/notice to be signed on its behalf by the undersigned
duly authorized person.
DATE: July 10, 2015 |
By: |
/s/ Scott M. Madson |
|
|
Scott M. Madson
Chief Financial Officer |
Urologix (CE) (USOTC:ULGX)
過去 株価チャート
から 4 2024 まで 5 2024
Urologix (CE) (USOTC:ULGX)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Urologix Inc (CE) (その他OTC): 0 recent articles
その他のUrologix Incニュース記事